Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 122950 | PF-3084014 | 1290543-63-3 | 98% |  |
| PF-3084014 is a novel -secretase inhibitor that reduces amyloid-beta (Abeta) producti | ||||
| 122941 | Pacritinib ( SB1518 ) | 937272-79-2 | ≧98.0% | _937272-79-2.png) |
| Pacritinib(SB1518) is a highly selective kinaseinhibitorwith specificity for JAK2, FL | ||||
| 122916 | PHA-848125 | 802539-81-7 | 98% |  |
| PHA-848125 is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM; &g | ||||
| 122908 | PI-3065 | 955977-50-1 | 98% |  |
| PI-3065 is a novel potent and selective PI3K p110 inhibitor with IC50 of 15 nM; exhib | ||||
| 122903 | PD 123319 | 130663-39-7 | 98% |  |
| PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of | ||||
| 122827 | PNU-282987 | 123464-89-1 | 98% |  |
| PNU-282987 is a selective 7 nicotinic acetylcholine receptor(7 nAChR) agonist with Ki | ||||
| 122818 | PF-431396 | 717906-29-1 | 98% |  |
| PF-431396 is dual focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK | ||||
| 122815 | Posaconazole | 171228-49-2 | 98% |  |
| Posaconazole is a broad-spectrum, second generation, triazole compound with antifunga | ||||
| 122806 | PQ401 | 196868-63-0 | 98% |  |
| PQ401, a selective insulin-like growth factor-1 receptor blocker, is a novel diarylur | ||||
| 122523 | Pardoprunox | 269718-84-5 | 98% |  |
| Pardoprunox is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT | ||||
| 122520 | PKC-IN-1 | 1046787-18-1 | 98% |  |
| PKC-IN-1 is a poent PKC beta II inhibitor with Ki of 14.9 nM; compound example H6 fro | ||||
| 122515 | PF-04447943 | 1082744-20-4 | 98% |  |
| PF-04447943 is a potent, selective brain penetrant PDE9 inhibitor (Ki of 2.8, 4.5 and | ||||
| 122405 | PD-0325901 | 391210-10-9 | 98% |  |
| PD-0325901 i a potent bioavailable and selective MEK inhibitor, which targets mitogen | ||||
| 122302 | P005672 hydrochloride | 1035979-44-2 | 98% |  |
| P005672 hydrochloride is used for antibacterial/anti-inflammatory acne treatment. | ||||
| 122216 | Pirodavir | 124436-59-5 | 98% |  |
| Pirodavir is the prototype of a novel class of broad-spectrum antipicornavirus compou | ||||
| 122212 | PD173074 | 219580-11-7 | 98% |  |
| PD173074 is a small-molecule FGFR3-selective tyrosine kinase inhibitor (TKI), as a th | ||||
| 121802 | Pyroxamide | 382180-17-8 | 98% |  |
| Pyroxamide is a synthetic derivative of hydroxamic acid with antineoplastic propertie | ||||
| 121421 | PKI-402 | 1173204-81-3 | 98% |  |
| PKI-402 is a potent dual pan-PI3K/mTOR inhibitor targeting PI3K/// and mTOR with IC50 | ||||
| 121418 | PHA-665752 | 477575-56-7 | 98% |  |
| PHA-665752 is a potent, selective and ATP-competitive c-Met inhibitor with IC50 of 9 | ||||
| 120809 | Pimavanserin | 706779-91-1 | 98% |  |
| Pimavanserin is an inverse agonist on the serotonin receptor subtype 5-HT2A, with 40x | ||||
| 120704 | Pemetrexed disodium | 150399-23-8 | 98% |  |
| Coming soon! | ||||
| 111307 | PX-478 | 685847-78-3 | 98% |  |
| PX-478 is HIF-1alpha inhibitor, is also an orally active small molecule with potentia | ||||
| 111010 | Pardoprunox hydrochloride | 269718-83-4 | 98% |  |
| Pardoprunox hydrochloride is a novel partial dopamine D2 and D3 receptor agonist and | ||||
| 111003 | PD153035 Hcl | 183322-45-4 | 98% |  |
| PD153035 Hcl is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM an | ||||
| 110904 | PRT-060318 | 1194961-19-7 | 98% |  |
| PRT-060318 is a novel selective inhibitor of the tyrosine kinase Syk, as an approach | ||||
| 110401 | PCI-27483 | 871266-63-6 | 98% |  |
| PCI-27483 is a reversible small-molecule inhibitor of activated factor VII (factor VI | ||||
| 110223 | PSEUDOLARIC ACID B | 82508-31-4 | 98% |  |
| Pseudolaric acid B is a diterpene acid isolated from the bark of Pseudolarix kaempfer | ||||
| 102616 | PL-100 | 612547-11-2 | 98% |  |
| PL-100 is a novel HIV-1 protease inhibitor (PI) with a favorable cross-resistance pro | ||||
| 102302 | propan-2-yl (2S)-2-[[(2,3,4,5,6-pentafluorophenoxy)-phenoxyphosphoryl]amino]propanoate | 1334513-02-8 | 98% | -2-[[(23456-pentafluorophenoxy)-phenoxyphosphoryl]amino]propanoate-cas-1334513-02-8.png) |
| Coming soon! | ||||
| 101919 | PF-562271 benzenesulfonate salt | 939791-38-5 | 98% |  |
| PF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion | ||||